
    
      Subjects will include patients with MRI-verified NAFLD, with no concurrent liver diseases.
      Randomization will be done to either a control diet, the 5:2 diet or a low-carb-high-fat
      diet. The subjects will follow the diet for three months, after which a new MRI is performed.
      Main outcomes measure is reduction in liver fat.
    
  